Adhezion Biomedical (Myomissing, PA) an early-stage device company focused on the development differentiated cyanoacrylate-based surgical, wound management and infection prevention technologies closed a $2.1M Series A financing, bringing the round total to $5.3M. Participants include Liberty Venture Partners.